CTLA4 and hepatocellular carcinoma: Collectively, these findings suggest that, while PD-1 and CTLA-4 gene expression levels may not serve as reliable diagnostic markers for HCC, they may serve as prognostic biomarkers for survival outcomes and highly malignant HCC subtypes.